Predicting the risk of metastases by PSMA-PET/CT: evaluation of 335 men with treatment-naïve prostate carcinoma

Men diagnosed with aggressive prostate cancer are at high risk of local relapse or systemic progression after definitive treatment. Treatment intensification is highly needed for that patient cohort; however, no relevant stratification tool has been implemented into the clinical work routine so far....

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Körber, Stefan A. (VerfasserIn) , Bösch, Johannes (VerfasserIn) , Kratochwil, Clemens (VerfasserIn) , Schlampp, Ingmar (VerfasserIn) , Ristau, Jonas (VerfasserIn) , Winter, Erik (VerfasserIn) , Zschäbitz, Stefanie (VerfasserIn) , Hofer, Luisa (VerfasserIn) , Herfarth, Klaus (VerfasserIn) , Kopka, Klaus (VerfasserIn) , Holland-Letz, Tim (VerfasserIn) , Jäger, Dirk (VerfasserIn) , Hohenfellner, Markus (VerfasserIn) , Haberkorn, Uwe (VerfasserIn) , Debus, Jürgen (VerfasserIn) , Giesel, Frederik L. (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 25 March 2021
In: Cancers
Year: 2021, Jahrgang: 13, Heft: 7, Pages: 1-11
ISSN:2072-6694
DOI:10.3390/cancers13071508
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.3390/cancers13071508
Verlag, lizenzpflichtig, Volltext: https://www.mdpi.com/2072-6694/13/7/1508
Volltext
Verfasserangaben:Stefan A. Koerber, Johannes Boesch, Clemens Kratochwil, Ingmar Schlampp, Jonas Ristau, Erik Winter, Stefanie Zschaebitz, Luisa Hofer, Klaus Herfarth, Klaus Kopka, Tim Holland-Letz, Dirk Jaeger, Markus Hohenfellner, Uwe Haberkorn, Juergen Debus and Frederik L. Giesel

MARC

LEADER 00000caa a2200000 c 4500
001 1759813753
003 DE-627
005 20231114083534.0
007 cr uuu---uuuuu
008 210604s2021 xx |||||o 00| ||eng c
024 7 |a 10.3390/cancers13071508  |2 doi 
035 |a (DE-627)1759813753 
035 |a (DE-599)KXP1759813753 
035 |a (OCoLC)1341415250 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Körber, Stefan A.  |e VerfasserIn  |0 (DE-588)1023031140  |0 (DE-627)717350053  |0 (DE-576)366291823  |4 aut 
245 1 0 |a Predicting the risk of metastases by PSMA-PET/CT  |b evaluation of 335 men with treatment-naïve prostate carcinoma  |c Stefan A. Koerber, Johannes Boesch, Clemens Kratochwil, Ingmar Schlampp, Jonas Ristau, Erik Winter, Stefanie Zschaebitz, Luisa Hofer, Klaus Herfarth, Klaus Kopka, Tim Holland-Letz, Dirk Jaeger, Markus Hohenfellner, Uwe Haberkorn, Juergen Debus and Frederik L. Giesel 
264 1 |c 25 March 2021 
300 |a 11 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 04.06.2021 
520 |a Men diagnosed with aggressive prostate cancer are at high risk of local relapse or systemic progression after definitive treatment. Treatment intensification is highly needed for that patient cohort; however, no relevant stratification tool has been implemented into the clinical work routine so far. Therefore, the aim of the current study was to analyze the role of initial PSMA-PET/CT as a prediction tool for metastases. In total, 335 men with biopsy-proven prostate carcinoma and PSMA-PET/CT for primary staging were enrolled in the present, retrospective study. The number and site of metastases were analyzed and correlated with the maximum standardized uptake value (SUVmax) of the intraprostatic, malignant lesion. Receiver operating characteristic (ROC) curves were used to determine sensitivity and specificity and a model was created using multiple logistic regression. PSMA-PET/CT detected 171 metastases with PSMA-uptake in 82 patients. A statistically significant higher SUVmax was found for men with metastatic disease than for the cohort without distant metastases (median 16.1 vs. 11.2; p < 0.001). The area under the curve (AUC) in regard to predicting the presence of any metastases was 0.65. Choosing a cut-off value of 11.9 for SUVmax, a sensitivity and specificity (factor 1:1) of 76.0% and 58.4% was obtained. The current study confirms, that initial PSMA-PET/CT is able to detect a relatively high number of treatment-naïve men with metastatic prostate carcinoma. Intraprostatic SUVmax seems to be a promising parameter for the prediction of distant disease and could be used for treatment stratification—aspects which should be verified within prospective trials. 
650 4 |a intraprostatic SUV 
650 4 |a metastases 
650 4 |a PET 
650 4 |a prostate cancer 
650 4 |a PSMA 
700 1 |a Bösch, Johannes  |d 1992-  |e VerfasserIn  |0 (DE-588)1217421777  |0 (DE-627)1729825834  |4 aut 
700 1 |a Kratochwil, Clemens  |d 1978-  |e VerfasserIn  |0 (DE-588)134026276  |0 (DE-627)559871686  |0 (DE-576)300262787  |4 aut 
700 1 |a Schlampp, Ingmar  |d 1982-  |e VerfasserIn  |0 (DE-588)1014278430  |0 (DE-627)705203255  |0 (DE-576)348136986  |4 aut 
700 1 |a Ristau, Jonas  |d 1989-  |e VerfasserIn  |0 (DE-588)1075216303  |0 (DE-627)83302986X  |0 (DE-576)443326444  |4 aut 
700 1 |a Winter, Erik  |d 1991-  |e VerfasserIn  |0 (DE-588)1196751358  |0 (DE-627)167862246X  |4 aut 
700 1 |a Zschäbitz, Stefanie  |d 1983-  |e VerfasserIn  |0 (DE-588)1037698827  |0 (DE-627)75589894X  |0 (DE-576)391727206  |4 aut 
700 1 |a Hofer, Luisa  |e VerfasserIn  |0 (DE-588)1076742556  |0 (DE-627)835277054  |0 (DE-576)445618019  |4 aut 
700 1 |a Herfarth, Klaus  |e VerfasserIn  |0 (DE-588)1032757582  |0 (DE-627)739273116  |0 (DE-576)171352289  |4 aut 
700 1 |a Kopka, Klaus  |e VerfasserIn  |4 aut 
700 1 |a Holland-Letz, Tim  |e VerfasserIn  |0 (DE-588)142336491  |0 (DE-627)658880470  |0 (DE-576)343311291  |4 aut 
700 1 |a Jäger, Dirk  |d 1964-  |e VerfasserIn  |0 (DE-588)1032507535  |0 (DE-627)738505323  |0 (DE-576)380074125  |4 aut 
700 1 |a Hohenfellner, Markus  |d 1958-  |e VerfasserIn  |0 (DE-588)133862518  |0 (DE-627)557857988  |0 (DE-576)300155263  |4 aut 
700 1 |a Haberkorn, Uwe  |d 1959-  |e VerfasserIn  |0 (DE-588)1022913905  |0 (DE-627)717331245  |0 (DE-576)366166352  |4 aut 
700 1 |a Debus, Jürgen  |d 1964-  |e VerfasserIn  |0 (DE-588)1022671421  |0 (DE-627)717025780  |0 (DE-576)365774944  |4 aut 
700 1 |a Giesel, Frederik L.  |d 1970-  |e VerfasserIn  |0 (DE-588)129031240  |0 (DE-627)387883878  |0 (DE-576)297457071  |4 aut 
773 0 8 |i Enthalten in  |t Cancers  |d Basel : MDPI, 2009  |g 13(2021), 7, Artikel-ID 1508, Seite 1-11  |h Online-Ressource  |w (DE-627)614095670  |w (DE-600)2527080-1  |w (DE-576)313958548  |x 2072-6694  |7 nnas  |a Predicting the risk of metastases by PSMA-PET/CT evaluation of 335 men with treatment-naïve prostate carcinoma 
773 1 8 |g volume:13  |g year:2021  |g number:7  |g elocationid:1508  |g pages:1-11  |g extent:11  |a Predicting the risk of metastases by PSMA-PET/CT evaluation of 335 men with treatment-naïve prostate carcinoma 
856 4 0 |u https://doi.org/10.3390/cancers13071508  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://www.mdpi.com/2072-6694/13/7/1508  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210604 
993 |a Article 
994 |a 2021 
998 |g 129031240  |a Giesel, Frederik L.  |m 129031240:Giesel, Frederik L.  |d 910000  |d 911400  |e 910000PG129031240  |e 911400PG129031240  |k 0/910000/  |k 1/910000/911400/  |p 16  |y j 
998 |g 1022671421  |a Debus, Jürgen  |m 1022671421:Debus, Jürgen  |d 910000  |d 911400  |e 910000PD1022671421  |e 911400PD1022671421  |k 0/910000/  |k 1/910000/911400/  |p 15 
998 |g 1022913905  |a Haberkorn, Uwe  |m 1022913905:Haberkorn, Uwe  |d 910000  |d 911400  |e 910000PH1022913905  |e 911400PH1022913905  |k 0/910000/  |k 1/910000/911400/  |p 14 
998 |g 133862518  |a Hohenfellner, Markus  |m 133862518:Hohenfellner, Markus  |d 910000  |d 910200  |e 910000PH133862518  |e 910200PH133862518  |k 0/910000/  |k 1/910000/910200/  |p 13 
998 |g 1032507535  |a Jäger, Dirk  |m 1032507535:Jäger, Dirk  |d 910000  |e 910000PJ1032507535  |k 0/910000/  |p 12 
998 |g 142336491  |a Holland-Letz, Tim  |m 142336491:Holland-Letz, Tim  |d 50000  |e 50000PH142336491  |k 0/50000/  |p 11 
998 |g 1032757582  |a Herfarth, Klaus  |m 1032757582:Herfarth, Klaus  |d 910000  |d 911400  |d 50000  |e 910000PH1032757582  |e 911400PH1032757582  |e 50000PH1032757582  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 9 
998 |g 1076742556  |a Hofer, Luisa  |m 1076742556:Hofer, Luisa  |d 910000  |d 910200  |e 910000PH1076742556  |e 910200PH1076742556  |k 0/910000/  |k 1/910000/910200/  |p 8 
998 |g 1037698827  |a Zschäbitz, Stefanie  |m 1037698827:Zschäbitz, Stefanie  |d 910000  |d 910100  |e 910000PZ1037698827  |e 910100PZ1037698827  |k 0/910000/  |k 1/910000/910100/  |p 7 
998 |g 1196751358  |a Winter, Erik  |m 1196751358:Winter, Erik  |d 910000  |d 911400  |e 910000PW1196751358  |e 911400PW1196751358  |k 0/910000/  |k 1/910000/911400/  |p 6 
998 |g 1075216303  |a Ristau, Jonas  |m 1075216303:Ristau, Jonas  |d 910000  |d 911400  |e 910000PR1075216303  |e 911400PR1075216303  |k 0/910000/  |k 1/910000/911400/  |p 5 
998 |g 1014278430  |a Schlampp, Ingmar  |m 1014278430:Schlampp, Ingmar  |d 910000  |d 911400  |e 910000PS1014278430  |e 911400PS1014278430  |k 0/910000/  |k 1/910000/911400/  |p 4 
998 |g 134026276  |a Kratochwil, Clemens  |m 134026276:Kratochwil, Clemens  |d 910000  |d 911400  |e 910000PK134026276  |e 911400PK134026276  |k 0/910000/  |k 1/910000/911400/  |p 3 
998 |g 1217421777  |a Bösch, Johannes  |m 1217421777:Bösch, Johannes  |d 50000  |e 50000PB1217421777  |k 0/50000/  |p 2 
998 |g 1023031140  |a Körber, Stefan A.  |m 1023031140:Körber, Stefan A.  |d 910000  |d 911400  |d 50000  |e 910000PK1023031140  |e 911400PK1023031140  |e 50000PK1023031140  |k 0/910000/  |k 1/910000/911400/  |k 0/50000/  |p 1  |x j 
999 |a KXP-PPN1759813753  |e 3934727859 
BIB |a Y 
SER |a journal 
JSO |a {"person":[{"display":"Körber, Stefan A.","family":"Körber","given":"Stefan A.","role":"aut"},{"family":"Bösch","given":"Johannes","role":"aut","display":"Bösch, Johannes"},{"display":"Kratochwil, Clemens","given":"Clemens","role":"aut","family":"Kratochwil"},{"display":"Schlampp, Ingmar","family":"Schlampp","role":"aut","given":"Ingmar"},{"display":"Ristau, Jonas","given":"Jonas","role":"aut","family":"Ristau"},{"display":"Winter, Erik","family":"Winter","role":"aut","given":"Erik"},{"display":"Zschäbitz, Stefanie","given":"Stefanie","role":"aut","family":"Zschäbitz"},{"display":"Hofer, Luisa","family":"Hofer","given":"Luisa","role":"aut"},{"display":"Herfarth, Klaus","role":"aut","given":"Klaus","family":"Herfarth"},{"display":"Kopka, Klaus","role":"aut","given":"Klaus","family":"Kopka"},{"role":"aut","given":"Tim","family":"Holland-Letz","display":"Holland-Letz, Tim"},{"display":"Jäger, Dirk","family":"Jäger","given":"Dirk","role":"aut"},{"display":"Hohenfellner, Markus","given":"Markus","role":"aut","family":"Hohenfellner"},{"display":"Haberkorn, Uwe","family":"Haberkorn","role":"aut","given":"Uwe"},{"display":"Debus, Jürgen","family":"Debus","role":"aut","given":"Jürgen"},{"role":"aut","given":"Frederik L.","family":"Giesel","display":"Giesel, Frederik L."}],"relHost":[{"part":{"volume":"13","year":"2021","extent":"11","text":"13(2021), 7, Artikel-ID 1508, Seite 1-11","issue":"7","pages":"1-11"},"id":{"zdb":["2527080-1"],"eki":["614095670"],"issn":["2072-6694"]},"pubHistory":["1.2009 -"],"name":{"displayForm":["Molecular Diversity Preservation International (MDPI)"]},"note":["Gesehen am 27.05.2020"],"language":["eng"],"type":{"bibl":"periodical","media":"Online-Ressource"},"title":[{"title_sort":"Cancers","title":"Cancers"}],"origin":[{"publisher":"MDPI","dateIssuedDisp":"2009-","dateIssuedKey":"2009","publisherPlace":"Basel"}],"disp":"Predicting the risk of metastases by PSMA-PET/CT evaluation of 335 men with treatment-naïve prostate carcinomaCancers","physDesc":[{"extent":"Online-Ressource"}],"recId":"614095670"}],"origin":[{"dateIssuedKey":"2021","dateIssuedDisp":"25 March 2021"}],"title":[{"subtitle":"evaluation of 335 men with treatment-naïve prostate carcinoma","title_sort":"Predicting the risk of metastases by PSMA-PET/CT","title":"Predicting the risk of metastases by PSMA-PET/CT"}],"note":["Gesehen am 04.06.2021"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"language":["eng"],"recId":"1759813753","physDesc":[{"extent":"11 S."}],"name":{"displayForm":["Stefan A. Koerber, Johannes Boesch, Clemens Kratochwil, Ingmar Schlampp, Jonas Ristau, Erik Winter, Stefanie Zschaebitz, Luisa Hofer, Klaus Herfarth, Klaus Kopka, Tim Holland-Letz, Dirk Jaeger, Markus Hohenfellner, Uwe Haberkorn, Juergen Debus and Frederik L. Giesel"]},"id":{"doi":["10.3390/cancers13071508"],"eki":["1759813753"]}} 
SRT |a KOERBERSTEPREDICTING2520